Skip to content
OpenCapital
Get started

Journey Medical Corporation DERM Debt-to-equity

Debt-to-equity at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
0.2×0.0×
PTH
Pelthos Therapeutics Inc.PTHS
0.8×—
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
0.6×-0.2×
HRO
HarrowHROW
10.7×+2.6×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
0×0.0×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
0.1×0.0×

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M—
Free cash flow-$6.0M—

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S3×+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%—
Net margin-14.8%—
FCF margin-43%—

Returns & leverage

See full
Return on equity-36.6%—
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

total debt/total stockholders equity=0.8×

Based on the most recent quarter.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's debt-to-equity?
Journey Medical Corporation (DERM) reported debt-to-equity of 0.8× in Q1 2026.
How has Journey Medical Corporation's debt-to-equity changed year-over-year?
Journey Medical Corporation's debt-to-equity decreased by 29.3% year-over-year, from 1.2× to 0.8×.
What is the long-term trend for Journey Medical Corporation's debt-to-equity?
Over 5 years (2020 to 2025), Journey Medical Corporation's debt-to-equity has grown at a 114.2% compound annual growth rate (CAGR), from 0× to 0.8×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.